Volume: 8 Issue: 3
Year: 2020, Page: 8-12, Doi: https://doi.org/10.47799/pimr.0803.03
Received: Aug. 20, 2020 Accepted: Sept. 29, 2020 Published: Sept. 29, 2020
Background: Psoriasis is a common disease presented to the dermatology clinics. There are several reports concerning co morbidities in patients with psoriasis. Some of them include diabetes mellitus, hypertension, dyslipidemia, obesity, IHD, ulcerative colitis. Hence, we in the present study tried to evaluate the existing comorbidities in patients diagnosed with psoriasis in presenting to our hospital.
Methods: This study was conducted in the Department of Dermatology, Venereology, and Leprosy, Prathima Institute of Medical Sciences, Karimnagar. This case-control study evaluated the prevalence of diabetes mellitus, hypertension, obesity, dyslipidemia and metabolic syndrome in patients with psoriasis. The existence of hypertension, diabetes mellitus, dyslipidemia, obesity was determined by standard criteria. The data was recorded and analyzed using SPSS version 17 for p values.
Results: BSL (Blood Sugar Level) derangement as increased fasting BSL was observed in 23 (23%) cases compared to 8(8%) controls. There was a statistically significant difference between psoriatic cases and controls. The total number of male patients with raised waist circumference was 24 (33.8%) compared to 9(13.2%) controls. There was a statistically significant association of raised waist circumference in psoriasis cases compared to controls, the p-value was <0.004. The existence of metabolic syndrome was 27% in the study group and 8% in the control group the p values were <0.004 and significant.
Conclusion: The results of the present shows that there is a significant prevalence of psoriasis in males as compared to females. There is a significant association of metabolic syndrome in patients with psoriasis. Hence all the patients with psoriasis need to be evaluated for metabolic syndrome which may be a risk factor for systemic diseases.
Keywords: Psoriasis, Co morbidities, Epidemiological Study.
1. Gudjonsson JE, Elder JT. Psoriasis: epidemiology. Clin Dermatol. 2007 Nov-Dec;25(6):535-46. doi: 10.1016/ j.clindermatol.2007.08.007. PMID: 18021890.
2. Albareda M, Ravella A, Castelló M, Saborit S, Peramiquel L, Vila L. Metabolic syndrome and its components in patients with psoriasis. Springerplus. 2014;3:612. Published 2014 Oct 17. doi:10.1186/2193-1801-3-612
3. Azfar RS, Gelfand JM. Psoriasis and Metabolic Diseases: Epidemiology and pathophysiology. CurrOpinRheumatol2008;20(4):416-22.
4. Menter A, Griffiths C, Tebbey P, Horn E, SterryW; on behalf of the International Psoriasis Council. Exploring the association between cardiovascular and other diseaserelated risk factors in the psoriasis population: The need for increased understanding across the medical community. J Eur Acad Dermatol Venereol2010;24:1371- 77.
5. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res2006; 298:321-28.
6. Gisondi P, Tessari G, Conti A, et al; Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based casecontrol study. Br J Dermatol2007;157:68-73
7. Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun2010; 34:314-21.
8. Raychaudhuri SP, Gross J. Psoriasis risk factors: role of lifestyle practices. Cutis2000;66:348-52.
9. Ena P, Madeddu P, Glorioso N, Cerimele D, Rappelli A. High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients. Acta Cardiol1985;40:199-05.
10. Bonifati C, Mussi A, Carducci M, Dauria L, Ameglio F. Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlatewith disease severity. Acta DermVenereol1998; 78:22-26.
11. Okhandiar RP, Banerjee BN. Psoriasis in the tropics: An epidemiological survey. J Indian Med Assoc. 1963;41:550– 56.
12. Bedi TR. Psoriasis in North India. Geographical variations.Dermatologica.1977;155:310–14.
13. Bedi TR. Clinical profile of psoriasis in North India. Indian J Dermatol VenereolLeprol1995;61:202-25.
14. Kaur I, Handa S, Kumar B. Natural history of psoriasis: Astudy from the Indian subcontinent. J Dermatol1997;24:230-24.
15. Asokan N, Prathap P et al. Pattern of psoriasis in a tertiary care Teaching Hospital in South India. Indian J Dermatol2011;56:118-19.
16. Okhandiar RP, Banerjee BN. Psoriasis in the tropics: An epidemiological survey. J Indian Med Assoc. 1963;41:550– 56.
17. Bedi TR. Psoriasis in north India. Geographical variations.Dermatologica.1977;155:310–14.
18. Bedi TR. Clinical profile of psoriasis in North India. Indian J Dermatol VenereolLeprol1995;61:202-5.
19. Kaur I, Handa S, Kumar B. Natural history of psoriasis: A study from the Indian subcontinent. J Dermatol1997;24:230-4
20. Asokan N, Prathap P et al. Pattern of psoriasis in a tertiary care teaching hospital in south India. Indian J Dermatol2011;56:118-9.
21. Ellie C. Stefanadi , Georgios Dimitrakakis, et al. Metabolic syndrome and the skin: a more than the superficial association. Reviewing the associationbetweenskin diseases and metabolic syndrome and a clinical decision algorithm for high-risk patients. DiabetolMetabSyndr 2018; 10:9
22. Nisa N, Qazi MA. Prevalence of metabolic syndrome in patients with psoriasis. Indian J Dermatol VenereolLeprol2010;76:662-5
23. Khunger N, Gupta D, et al. Is psoriasis a new cutaneous marker for metabolic syndrome? A study in Indian patients. Indian J Dermatol 2013;58:313-4.
24. Ali NM, Kuruvila M, Unnikrishnan B. Psoriasis and metabolicsyndrome: A case control study. Indian J Dermatol VenereolLeprol2014;80:255-7.
25. Madanagobalane S, Ananda S. Prevalence of metabolic syndrome in South Indian patients with psoriasis Vulgaris and the relation between disease severity and metabolic syndrome: A hospital-based case-control study. Indian J Dermatol 2012;57:353-7.
26. Kothiwala SK, Khanna N, et al. Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: A hospital-based cross-sectional study. Indian J Dermatol VenereolLeprol2016;82:510-8.
27. Sharma YK, Prakash N, Gupta A. Prevalence of metabolic syndrome as per the NCEP and IDF definitions vis-a-vis severity and duration of psoriasis in a semi-urban Maharashtrian population: A case-control study. Diabetes MetabSyndr2016
28. Aarti sudamsulanke et al. Association of Metabolic Syndrome in Chronic Plaque Psoriasis Patients and their Correlation with Disease Severity, Duration, and Age: A Case-Control Study From Western Maharashtra. Journal of Clinical and Diagnostic Research. 2017 Aug, Vol-11(8): WC06- WC10.
29. Banavasi S Girisha, NeethaThomas.Metabolic syndrome in Psoriasis among Urban South Indians: A Case-Control Study Using SAM-NCEP Criteria.Journal of Clinical and Diagnostic Research. 2017 Feb, Vol- 11(2): WC01-WC04.
© 2020-21 Prathima Institue of Medical Sciences
SK Jaffer Basha . Clinic epidemiological evaluation of co morbidities in patients with psoriasis in a tertiary care hospital. Perspectives in Medical Research 2020; 8 (3):8-12 DOI: 10.47799/pimr.0803.03